Table 1 Baseline characteristics of study participants
Variable | PP | Placebo | P value | |
|---|---|---|---|---|
Age (years) | 42.8 ± 7.2 | 43.3 ± 10.1 | 0.81 * | |
Women | 21 (53.8) | 18 (48.6) | 0.65 | |
Type 2 diabetes | 3 (7.7) | 3 (8.1) | 0.99 | |
Cardiovascular disease | 5 (12.8) | 3 (8.1) | 0.71 | |
Hyperlipidemia | 13 (33.3) | 12 (32.4) | 0.62 | |
Hypertension | 6 (15.4) | 6 (16.2) | 0.99 | |
Smoking and others | 5 (12.8) | 6 (16.2) | 0.67 | |
Physical Activity | Low | 19 (48.7) | 18 (48.6) | 0.99 |
Medium | 19 (48.7) | 18 (48.6) | ||
High | 1 (2.6) | 1 (2.7) | ||
BMI Classification (kg/m2) | Underweight | 0 (0) | 1 (2.7) | 0.15 |
Normal | 1 (2.6) | 0 (0) | ||
Overweight | 14 (35.9) | 22 (59.5) | ||
Obese | 24 (61.5) | 14 (37.8) | ||